m+Medelevator.RU
← Поиск публикаций
Obesity science & practice · 2024

Results of a pilot sequential multiple assignment randomized trial using counseling to augment a digital weight loss program.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Martinez Caitlin E, Nezami Brooke T, Mayer-Davis Elizabeth, Willis Erik A, Gorin Amy A, Tate Deborah F

Аннотация

OBJECTIVE: Adaptive interventions may improve the potency and scalability of behavioral weight loss interventions, but the treatments-or treatment combinations-that should be offered are unknown. A two-stage pilot sequential multiple assignment randomized trial was used to test the timing and dose of human support added to a core digital weight loss program.

METHODS: In stage 1, 99 adults with overweight/obesity were randomized at baseline to a kick-off with or without additional human support. In stage 2, "early non-responders" who had not achieved a 2% weight loss were re-randomized after 4 weeks to either biweekly counseling (120 min over 8 weeks) or a one-time check-in (30 min) with a dietitian. "Early responders" continued with the mHealth program alone. Feasibility and acceptability were assessed against pre-specified criteria. Preliminary outcomes (weight loss, self-monitoring and behavioral goal adherence) were explored.

RESULTS: The study met all feasibility and acceptability criteria. The rate of early response was 52.5%. Mean (SE) 3-month percent weight losses were significantly greater in early responders (-6.63% (0.72)) than non-responders (-1.70% (0.43), p < 0.001). Outcomes were similar by first- and second-line treatment though more counseling (27.3%) than check-in (12.5%) participants achieved a 5% weight loss.

CONCLUSIONS: Identifying early responders may help optimize weight loss interventions, but more research is needed on rescue treatments for early non-responders.

TRIAL REGISTRATION: ClinicalTrial.gov, NCT05929469.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты